敌意 发表于 2025-3-25 04:29:29

http://reply.papertrans.cn/1/47/4669/4669-21.png

排出 发表于 2025-3-25 10:02:11

http://reply.papertrans.cn/1/47/4669/4669-22.png

tenuous 发表于 2025-3-25 14:10:41

http://reply.papertrans.cn/1/47/4669/4669-23.png

蒸发 发表于 2025-3-25 18:28:48

Submitted on: 07 April 1998.
Revised on: 13 May 1998.
Accepted on: 28 June 1998.

___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

血统 发表于 2025-3-25 23:28:04

Submitted on: 21 March 2011.
Revised on: 30 May 2011.
Accepted on: 01 July 2011.

___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

人类的发源 发表于 2025-3-26 02:23:47

Submitted on: 07 October 1998.
Revised on: 22 November 1998.
Accepted on: 23 December 1998.

___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

身体萌芽 发表于 2025-3-26 06:46:37

http://reply.papertrans.cn/1/47/4669/4669-27.png

招募 发表于 2025-3-26 12:28:08

http://reply.papertrans.cn/1/47/4669/4669-28.png

ONYM 发表于 2025-3-26 15:37:50

Submitted on: 01 January 2019.
Revised on: 18 March 2019.
Accepted on: 25 April 2019.

___________________CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

起来了 发表于 2025-3-26 17:25:54

http://reply.papertrans.cn/1/47/4669/4669-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 2024/2025影响因子:2.496 (CANCER BIOTHER RADIO) (1084-9785). (MEDICINE, RES